Featured Posts
- Facebook Loses Reexaminations of Pragmatus’ Patents
- How is Reexamination Treating Round Rock Research?
- Reexamination has not Saved Apple against MobileMedia Patents, So Far
- What is an “Involved Application” in IPR Practice?
- Apple Victorious over Affinity Labs of Texas’ Portable Audio Player Patent
- Think IP Strategy Offers 2011 News Almanac
- An Update on Oracle’s Infringement Case against Google
- PTO Requests Public Comment on Proposed Rules for AIA Post-Issuance Proceedings
- Microsoft-i4i, Oracle-Google & VirnetX-Apple-Cisco Updates
- Oracle Patent to Emerge from Reexamination
- VirnetX again Sues for Infringement, and again Faces Reexaminations
- How Strong are Google’s Requests for Reexamination of the Lodsys Patents?
- PTO Board Sides with NVIDIA on Two Rambus “Barth I” Patents
- Oracle ‘520 Moves toward Confirmation in Reexamination
- Google Gets Mixed Result against Oracle’s Seventh Patent
- Did Google Request Reexamination of Lodsys Patents?
- Two Updates
- Oracle v. Google Android® Update
- Rambus Wins Limited Exclusion Order at ITC against NVIDIA, despite Pending Reexaminations
- 最初が肝心：不備のない再審査請求書を作成するために
- That’s My Patent You’re Reexamining…
- “Why Wait for Oppositions?” by Scott Daniels, 47 IDEA 343 (Law Review of Franklin Pierce Law School)
- The Basics
Noteworthy Links
- "The Interplay between Reexaminations, Preliminary Injunctions and Stays of Litigation" - by Dennis Crouch at PATENTLYO.COM
Favorite Patent Blogs
- All Things Pros
- CAFC Alert
- FDA Law Blog
- IPWatchdog
- Patent Docs
- Patently-O
- PLI Patent Law Practice Center
- Think IP Strategy
- US Patent Post-Grant Opposition
Recent Requests
PTO Statistics
Two Quick Notes
| April 3, 2012
1. “Troll Buster” Requests Reexamination
Is it possible to file a reexamination request over the weekend? Of course, and Jeff Oster, aka, “Troll Buster” proved it by requesting reexamination of two nucleic acid probe patents on Sunday (April Fool’s Day, no less) – U.S. Patent Nos. 5,538,848 & 5,723,591.
The parallel infringement action in the Northern District of California, however, is a serious matter. There, Applied Biosystems and Life Technologies have sued Midland Certified Reagent, Biosearch Technologies and Bio-Synthesis in February for infringement of the ‘848 and ‘591 patents, plus three other patents claiming hybridization assay probes. Presumably, reexamination requests for the other three patents are on the way.
2. PTO Board Affirms Rejection of Genzyme’s Doxercalciferol Patent
Last Thursday, the Patent Office Board of Appeals affirmed the reexamination rejection of the claims of Genzyme’s U.S. Patent No. 7,148,211 as obvious over the prior art. The ‘211 patent, that has been the subject of several major infringement actions in Delaware and the Eastern District of Illinois, claims a parenteral formulation containing doxercalciferol with a specific antioxidant.
Ten days ago, Judge Robert M. Dow determined that a related Genzyme patent was valid and infringed by Pentech Pharmaceutical and Cobrek Pharmaceutical.
